Directors

Jeffrey Woyda, Non Executive Director, bought 2,419 shares in the company on the 23rd March 2021 at a price of £6.20. The Director now holds...

Jonathan Gunby, Executive Director, has transferred in 58 shares in the company on the 22nd March 2021 at a price of £0.00. The Director now...

Jonathan Gunby, Executive Director, bought 29 shares in the company on the 22nd March 2021 at a price of £5.03. The Director now holds 748,291...

Alexander Scott, Financial Director, bought 29 shares in the company on the 22nd March 2021 at a price of £5.03. The Director now holds 1,182,541...

Alexander Scott, Financial Director, has transferred in 58 shares in the company on the 22nd March 2021 at a price of £0.00. The Director now...

Nicholas Taylor, Executive Director, exercised 23,700 shares in the company on the 23rd March 2021 at a price of £0.63. The Director now holds 141,240...

Richard Rose, Executive Director, sold 60,667 shares in the company on the 18th March 2021 at a price of £0.00. The Director now holds 491,923...

Richard Rose, Executive Director, has transferred in 129,077 shares in the company on the 18th March 2021 at a price of £0.00. The Director now...

The board of directors of GlaxoSmithKline, the majority shareholder of Galvani Bioelectronics, has announced the termination of Moncef Slaoui as chair of the Galvani board...

Frenkel Topping Group has appointed professor Dominic Regan as director of training and insight.

Professor Regan joins the firm to lead its training division, The...